The safety of quinolones-A meta-analysis of pregnancy outcomes

Benjamin Bar-Oz, Myla E. Moretti, Radinka Boskovic, Lisa O'Brien, Gideon Koren

פרסום מחקרי: פרסום בכתב עתמאמרביקורת עמיתים

73 ציטוטים ‏(Scopus)

תקציר

Objective: We conducted a meta-analysis of all published data in order to evaluate the risk for birth defects, stillbirths, preterm births and low birth weight following exposure to quinolones in the first trimester of pregnancy. Study design: Medline, Embase, Scopus, Biological Abstracts and Proquest Thesis Dissertation databases were searched. Other papers and abstracts were located from the retrieved articles' references, meeting booklets, internet web sites and books on teratology. Results: Five studies met the inclusion criteria. The summary odds ratio for all the included studies was 1.05 (95% CI 0.90-1.22) for major malformations, 2.6 (95% CI 0.36-18.67) for stillbirths, 1.15 (95% CI 0.69-1.91) for preterm births and 0.73 (95% CI 0.30-1.79) for low birth weight. In an additional analysis including only fluoroquinolones (nalidixic acid was removed), the summary odds ratio for major malformations remained non-significant (1.11, 95% CI 0.57-2.15). Conclusions: The use of quinolones during the first trimester of pregnancy does not appear to represent an increased risk for major malformations recognized after birth, stillbirths, preterm births or low birth weight.

שפה מקוריתאנגלית
עמודים (מ-עד)75-78
מספר עמודים4
כתב עתEuropean Journal of Obstetrics, Gynecology and Reproductive Biology
כרך143
מספר גיליון2
מזהי עצם דיגיטלי (DOIs)
סטטוס פרסוםפורסם - אפר׳ 2009
פורסם באופן חיצוניכן

טביעת אצבע

להלן מוצגים תחומי המחקר של הפרסום 'The safety of quinolones-A meta-analysis of pregnancy outcomes'. יחד הם יוצרים טביעת אצבע ייחודית.

פורמט ציטוט ביבליוגרפי